John Bernard Payne bought $100k of ZIVO
President and CEO at Zivo Bioscience, Inc.. 6,343 shares at an average of $15.76, traded Oct 16, 2024, filed Oct 16, 2024.
Score components
- +25RoleCEO
- +10Trade size$100k at market
- +10Relative to holdingsHoldings up 405%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +4.6%, 3m -14.0%, 6m -26.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001654954-24-013034, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 16, 2024 | POpen-market purchase Common Stock | +6,343 | $15.76 | $100k | 7,909 | Oct 16, 2024 |
| Oct 16, 2024 | POpen-market purchase Common Stock Warrantderivative | +634 | $15.77 | $9,995 | 634 | Oct 16, 2024 |
Related signals
Other insiders at Zivo Bioscience, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | ZIVObuy Zivo Bioscience, Inc. | Mark E Strome owner | $200k 100,000 shares | +21% | |
| 23Weak | ZIVObuy Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $15k 1,543 shares | +0% | |
| 35Weak | Zivo Bioscience, Inc. | Mark E Strome owner | $195k 20,000 shares | +4% | |
| 31Weak | Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $25k 2,434 shares | +0% | |
| 48Moderate | Zivo Bioscience, Inc. | Alison A Cornell director | $100k 11,709 shares | +4% | |
| 68Notable | Zivo Bioscience, Inc. | John Bernard Payne President and CEO | $100k 11,709 shares | +148% | |
| 33Weak | Zivo Bioscience, Inc. | Christopher D. Maggiore director, owner | $15k 1,766 shares | +0% | |
| 38Weak | Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $15k 1,766 shares | +0% | |
| 23Weak | ZIVObuy Zivo Bioscience, Inc. | Laith L Yaldoo director, owner | $25k 2,777 shares | +0% | |
| 43Moderate | Zivo Bioscience, Inc. | Mark E Strome owner | $250k 20,259 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.